Compare Cigna Corp (CI) vs WD 40 Company (WDFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs WD 40 Company — how do they compare? Cigna Corp trades at $304.26 (market cap $80.25B), while WD 40 Company trades at $249.35 (market cap $3.35B). The key difference: Cigna Corp is far larger — about 24× WD 40 Company's market cap, and Cigna Corp pays the higher dividend (2.06%). Which is the better fit depends on your goals.
| CI | WDFC | |
|---|---|---|
Market Cap | $80.25B | $3.35B |
Sector | Health | Technology |
52-Week High | $311.00 | $264.91 |
52-Week Low | $244.41 | $187.52 |
Enterprise Value | $103.35B | $3.40B |
Dividend Yield | 2.06% | 1.64% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $304.50, up 3.76% today, with a bullish technical outlook and strong analyst support. The stock shows consistent earnings beats, with Q1 2026 EPS of $7.79 exceeding the $7.60 estimate. Valuation metrics appear attractive with a P/E of 12.91 and P/S of 0.29. Recent news highlights strategic AI investments in pharmacy services and positive sector sentiment.
The investment case centers on undervaluation, earnings momentum, and dividend yield, though risks include regulatory challenges and moderating cash flow. With a consensus price target of $339.82 implying 11.6% upside, Wall Street maintains a bullish stance, but investors should weigh execution risks against growth initiatives.
WDFC trades at $251.43, down 5.09% today but maintains a bullish technical outlook with strong moving average signals. The company reported robust Q2 2026 earnings of $2.33 per share, beating estimates by 47%, driven by broad-based sales growth. Valuation remains elevated with a P/E of 37.88 and P/S of 5, while profitability metrics show a net income margin of 13.22% and ROE of 11%. Recent news highlights WD-40's strong brand moat and inclusion in Zacks' Strong Buy list on July 15, 2026.
Outlook is positive given earnings momentum and brand strength, but high valuation and margin pressures from input costs pose risks. Analyst consensus is mixed with 71% hold ratings, suggesting cautious optimism. The stock offers growth potential but requires monitoring of cost management and competitive dynamics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About WD 40 Company
WD-40 Company is a global marketing organization dedicated to creating 'positive lasting memories' by developing and selling products that solve maintenance and cleaning problems. Built around the legendary WD-40 Multi-Use Product, the company operates an asset-light business model, focusing on brand management and innovation while utilizing a network of contract manufacturers to deliver solutions across the Americas, EIMEA, and Asia-Pacific.
Read more on WDFC →
